Literature DB >> 16472931

An overview of medications for the treatment of alcohol withdrawal and alcohol dependence with an emphasis on the use of older and newer anticonvulsants.

Nassima Ait-Daoud1, Robert J Malcolm, Bankole A Johnson.   

Abstract

There is a growing interest in the development of new pharmacological tools for treating alcohol withdrawal and dependence. A number of anticonvulsants including valproate and carbamazepine have been shown to be safe and effective alternatives to benzodiazepines for treating alcohol withdrawal. These agents are relatively safe, are free from demonstrated abuse liability, and do not usually potentiate the psychomotor and cognitive effects of alcohol. For the treatment of alcohol dependence, there is a growing literature on the utility of medications that have neurochemical effects at opioid, serotonergic, GABAergic, and glutamate receptors. Furthermore, as a class of medication, there appears to be a growing interest in investigating the utility of novel anticonvulsants such as topiramate for the treatment of alcohol dependence.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16472931     DOI: 10.1016/j.addbeh.2005.12.029

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  13 in total

1.  Ethosuximide Reduces Mortality and Seizure Severity in Response to Pentylenetetrazole Treatment During Ethanol Withdrawal.

Authors:  Melissa A Riegle; Melissa L Masicampo; Hong Qu Shan; Victoria Xu; Dwayne W Godwin
Journal:  Alcohol Alcohol       Date:  2015-04-12       Impact factor: 2.826

2.  Placebo-controlled trial of zonisamide for the treatment of alcohol dependence.

Authors:  Albert J Arias; Richard Feinn; Cheryl Oncken; Jonathan Covault; Henry R Kranzler
Journal:  J Clin Psychopharmacol       Date:  2010-06       Impact factor: 3.153

Review 3.  Novel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulation.

Authors:  Giovanni Addolorato; Lorenzo Leggio; F Woodward Hopf; Marco Diana; Antonello Bonci
Journal:  Neuropsychopharmacology       Date:  2011-10-26       Impact factor: 7.853

Review 4.  Medication treatment of different types of alcoholism.

Authors:  Bankole A Johnson
Journal:  Am J Psychiatry       Date:  2010-06       Impact factor: 18.112

5.  Integrated Care of Alcohol-Related Liver Disease.

Authors:  Gerald S Winder; Anne C Fernandez; Jessica L Mellinger
Journal:  J Clin Exp Hepatol       Date:  2022-01-31

6.  Ethosuximide reduces electrographical and behavioral correlates of alcohol withdrawal seizure in DBA/2J mice.

Authors:  Melissa A Riegle; Melissa L Masicampo; Erin H Caulder; Dwayne W Godwin
Journal:  Alcohol       Date:  2014-05-04       Impact factor: 2.405

7.  Comparing and Combining Topiramate and Aripiprazole on Alcohol-Related Outcomes in a Human Laboratory Study.

Authors:  Carolina L Haass-Koffler; Kimberly Goodyear; William H Zywiak; Lorenzo Leggio; George A Kenna; Robert M Swift
Journal:  Alcohol Alcohol       Date:  2018-05-01       Impact factor: 2.826

8.  Selective Blockade of T-Type Ca2+ Channels is Protective Against Alcohol-Withdrawal Induced Seizure and Mortality.

Authors:  Melissa L Masicampo; Hong Qu Shan; Victoria Xu; Merritt Speagle; Dwayne W Godwin
Journal:  Alcohol Alcohol       Date:  2018-09-01       Impact factor: 2.826

Review 9.  Communication networks in the brain: neurons, receptors, neurotransmitters, and alcohol.

Authors:  David M Lovinger
Journal:  Alcohol Res Health       Date:  2008

10.  Cost-effectiveness analysis of baclofen and chlordiazepoxide in uncomplicated alcohol-withdrawal syndrome.

Authors:  Vikram K Reddy; K Girish; Pandit Lakshmi; R Vijendra; Ajay Kumar; R Harsha
Journal:  Indian J Pharmacol       Date:  2014 Jul-Aug       Impact factor: 1.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.